October 6-7, 2010 BioContact Québec Québec, QC
August 4, 2010
Gemin X Announces $8 Million Series E Financing
April 20, 2010
Gemin X Announces $16 Million Series D Financing
March 29, 2010
Gemin X Completes Patient Enrollment in Phase 2 Clinical Study of Obatoclax for First-Line Treatment of Small Cell Lung Cancer
